( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
6258
6360.6
6502.8
5961.8
Total Expenditure
5285.2
5326.9
5437.8
5009.6
PBIDT (Excl OI)
972.8
1033.7
1065
952.2
Other Income
149.5
76.5
104.5
137.8
Operating Profit
1122.3
1110.2
1169.5
1090
Exceptional Items
-8.2
-158.4
NA
-336.4
PBDT
1098.8
934.90
1151.6
739
Depreciation
118.7
171.9
127.1
145.5
Profit Before Tax
980.09
763.00
1024.5
593.5
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
736.99
565.60
769
354.5
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
736.99
565.60
769
354.5
Minority Interest
NA
NA
NA
NA
Shares of Associates
-2.7
0.8
-2.2
-2.1
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
734.3
566.4
766.8
352.4
Equity Capital
137
137
137
137
Calculated EPS
5.35
4.13
5.59
25.72
Calculated EPS (Annualised)
21.43
16.53
22.38
102.89
No of Public Share Holdings
34247308
34247308
NA
NA
% of Public Share Holdings
25
25
NA
NA
PBIDTM% (Excl OI)
15.54
16.25
16.37
15.97
PBIDTM%
17.93
17.45
17.98
18.28
PBDTM%
17.55
14.69
17.70
12.39